
About Indus Biotech
Indus Biotech is a Healthcare company based in Pune (India) founded in 1997 by Ranjeet Palliyil Srinivasan. Drugs for autoimmune, CNS, infectious, and lifestyle diseases are developed. Indus Biotech has raised $5.27 million across 1 funding round. The company has 138 employees. Its Indian entity Indus Biotech Limited reported revenue of ₹71.42 Cr. Indus Biotech offers products and services including Testosurge®, Fenuflakes®, Vinomerix®, Torabolic®, and Sugaheal®. Its focus areas include Diversified Pharmaceuticals, Biopharma Outsourcing, CRO and Drug Discovery.
Company details
Founded in 1997, Indus Biotech operates as a drug discovery company in the biotechnology sector, based in Pune, India. Focus is placed on identifying and developing treatments for autoimmune, oncology, central nervous system, infectious, and lifestyle diseases. Current products encompass torabolic for mass building, testosurge for testosterone bioavailability enhancement, biocreat for creatine delivery to muscle tissue, and testofen for libido support. Operations emphasize research and product innovation.
- Headquarters Pune, India
- Employees 138
- Founders Ranjeet Palliyil Srinivasan
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website indusbiotech.com
- Social LinkedIn
- Legal Name Indus Biotech Limited
- Date of Incorporation 16 Feb, 1995
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹71.42 Cr
FY 2025 · +2% YoY
- Net Profit₹3.68 Cr
FY 2025 · 5% margin
- EBITDA₹10.88 Cr
FY 2025 · 15% margin
- Total Equity Funding$5.27M (USD)
in 1 rounds
- Latest Funding Round$5.27M (USD), Series A
Jun 2007
- Employee Count138
Associated legal entities of Indus Biotech
Indus Biotech is associated with 2 registered companies on The Company Check; the primary company is Indus Biotech Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Indus Biotech Limited CIN U24231MH1995PLC085656 | Active | 16 Feb 1995 | Pune, Maharashtra | ₹71.4 Cr | 138 | 9 | View details |
| Trigonella Labs Private Limited CIN U74999PN2017PTC172331 | Active | 01 Sep 2017 | Pune, Maharashtra | ₹0.1 Cr | 113 | 3 | View details |
Products & Services of Indus Biotech
Indus Biotech offers a comprehensive portfolio of products and services, including Testosurge®, Fenuflakes®, Vinomerix®, Torabolic®, and Sugaheal®.
Increases testosterone levels through natural, clinically proven extracts.
Supports blood sugar management with high-fiber fenugreek extract.
Provides grape seed extract for improved health and circulation benefits.
Boosts lean mass and strength via fenugreek-based formulation.
Helps maintain healthy glucose levels in diabetes management.
Alleviates allergic rhinitis symptoms using cinnamon bark extract.
Funding Insights of Indus Biotech
Indus Biotech has successfully raised a total of $5.27M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.27 million completed in June 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.27M
- Total Rounds 1
- Last Round Series A — $5.27M
- First Round $5.27M
(Jun 2007)
All 1 funding rounds of Indus Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2007 | $5.27M | Series A | – | – | – |
Board of directors of Indus Biotech Limited (Indus Biotech)
Indus Biotech Limited is the primary company behind Indus Biotech. The boards of the 2 registered companies of Indus Biotech currently have 9 directors; the longest-serving is Ranjeet Palliyil Srinivasan, appointed in 1995. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ranjeet Palliyil Srinivasan DIN 00565528 | Director | 16 Feb 1995 | 31 yrs 9 mo | Indus Biotech Limited |
| Sunil Dutt Bhaskaran DIN 01499046 | Managing Director | 16 Feb 1995 | 31 yrs 9 mo | Indus Biotech Limited |
| Rajan Ramaswamy Srinivasan DIN 00485816 | Director | 01 Jan 2001 | 25 yrs 10 mo | Indus Biotech Limited |
| Sanjeev Sekhar DIN 07926201 | Director | 01 Sep 2017 | 9 yrs 2 mo | Trigonella Labs Private Limited |
| Aditya Sunil Bhaskaran DIN 07926202 | Director | 01 Sep 2017 | 9 yrs 2 mo | Trigonella Labs Private Limited |
| Achyut Jayatirthrao Huilgol DIN 07926200 | CFO | 14 Mar 2018 | 8 yrs 8 mo | Indus Biotech Limited, Trigonella Labs Private Limited |
| Shrikant Jayawant Patil DIN 01501715 | Director | 15 Nov 2021 | 5 yrs | Indus Biotech Limited |
| Anil Pratap Kumar DIN 00466438 | Director | 15 Nov 2021 | 5 yrs | Indus Biotech Limited |
| Pankaj Mehra DIN 00504916 | Director | 26 Sep 2025 | 1 yr 1 mo | Indus Biotech Limited |
People of Indus Biotech
1 people are tracked at Indus Biotech (1 in leadership); the tracked headcount is 138.
| Name | Role | Group |
|---|---|---|
| Founder | Leadership |
Complete people profiles for Indus Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Indus Biotech
Figures of Indus Biotech Limited, the primary company behind Indus Biotech, for FY 2025. Revenue was ₹71.42 Cr (+2% year on year). Net profit was ₹3.68 Cr (5% margin). EBITDA was ₹10.88 Cr (15% margin). Revenue has grown at a compounded annual rate of -10% over three years and -7% over five years.
- ₹71.42 CrRevenue · FY 2025 · +2% YoY
- ₹3.68 CrNet profit · 5% margin
- ₹10.88 CrEBITDA · 15% margin
- ₹10.48 CrPaid-up capital
- 138Employees (provident fund records)
- -10%Revenue CAGR, 3 years
- -7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Indus Biotech Limited are on its company page.
Detailed financial statements for Indus Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Indus Biotech
2 dated milestones of Indus Biotech across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Indus Biotech is founded.
- Funding First funding round of $5.3M.
Web traffic of Indus Biotech
The website of Indus Biotech (indusbiotech.com) receives about 2.5K visits a month and ranks #3,248,517 among all websites worldwide, #4,264 in Biotechnology and Pharmaceuticals.
- Monthly visits2.5K
▲ 3.6% vs previous month
- Global rank#3,248,517
among all websites
- Category rank#4,264
Health · Biotechnology and Pharmaceuticals
- Bounce rate28%
- Pages per visit11.8
- Average visit11 min 05 sec
- DevicesDesktop 72% · Mobile 28%
Websites whose visitors overlap most with Indus Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| jubilantbiosys.com | 100% | 12.2K | #2,731,637 | View details | |
lupinworld.com | lupinworld.com | 98% | – | ||
| martinandpleasance.com | 58% | #1,148,115 | View details | ||
| geneombiotechnologies.com | 39% | View details | |||
| ajaybiotech.com | 39% | 1.3K | #11,484,262 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Indus Biotech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Indus Biotech (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Indus Biotech
Complete news archive for Indus Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indus Biotech
Indus Biotech was founded in 1997 and raised its 1st funding round 10 years after it was founded.
Indus Biotech is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Indus Biotech is a funded company, having raised a total of $5.27M across 1 funding round to date. The company's 1st funding round was a Series A of $5.27M, raised on Jun 2007.
Indus Biotech has 138 employees.
The primary company behind Indus Biotech, Indus Biotech Limited, reported revenue of ₹71.42 Cr for FY 2025, up 2% year on year.
Founded in 1997, Indus Biotech operates as a drug discovery company in the biotechnology sector, based in Pune, India. Focus is placed on identifying and developing treatments for autoimmune, oncology, central nervous system, infectious, and lifestyle diseases. Current products encompass torabolic for mass building, testosurge for testosterone bioavailability enhancement, biocreat for creatine delivery to muscle tissue, and testofen for libido support. Operations emphasize research and product innovation.
Indus Biotech offers Testosurge®, Fenuflakes®, Vinomerix®, Torabolic®, and 2 more products and services.
Indus Biotech is associated with 2 legal entities: Indus Biotech Limited, Trigonella Labs Private Limited.
The legal entities of Indus Biotech currently have 10 directors, including Rajan Ramaswamy Srinivasan, Achyut Jayatirthrao Huilgol, Ranjeet Palliyil Srinivasan and others.
